Italy Diabetes Devices Market Size & Outlook, 2026-2033

The diabetes devices market in Italy is expected to reach a projected revenue of US$ 3,313.0 million by 2033. A compound annual growth rate of 10.3% is expected of Italy diabetes devices market from 2026 to 2033.
Revenue, 2025 (US$M)
$1,518.6
Forecast, 2033 (US$M)
$3,313.0
CAGR, 2026 - 2033
10.3%
Report Coverage
Italy

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Italy diabetes devices market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Italy diabetes devices market highlights

  • The Italy diabetes devices market generated a revenue of USD 1,518.6 million in 2025 and is expected to reach USD 3,313.0 million by 2033.
  • The Italy market is expected to grow at a CAGR of 10.3% from 2026 to 2033.
  • In terms of segment, blood glucose monitoring (bgm) devices was the largest revenue generating type in 2025.
  • Blood Glucose Monitoring (BGM) Devices is the most lucrative type segment registering the fastest growth during the forecast period.


Diabetes devices market data book summary

Market revenue in 2025USD 1,518.6 million
Market revenue in 2033USD 3,313.0 million
Growth rate10.3% (CAGR from 2026 to 2033)
Largest segmentBlood glucose monitoring (bgm) devices
Fastest growing segmentBlood Glucose Monitoring (BGM) Devices
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationInsulin Delivery Devices, Blood Glucose Monitoring (BGM) Devices
Key market players worldwideMedtronic PLC, Abbott Laboratories, Roche Holding AG, Bayer AG, Johnson & Johnson, B. Braun, DexCom Inc, Insulet Corp, Ypsomed Holding AG, Sanofi SA, Novo Nordisk A/S ADR, Arkray


Other key industry trends

  • In terms of revenue, Italy accounted for 3.3% of the global diabetes devices market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany diabetes devices market is projected to lead the regional market in terms of revenue in 2033.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 4,547.8 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Diabetes Devices Market Companies

Name Profile # Employees HQ Website
Ypsomed Holding AG View profile 2400 Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 https://www.ypsomed.com
DexCom Inc View profile 9600 6340 Sequence Drive, San Diego, CA, United States, 92121 https://www.dexcom.com
Arkray View profile 5001-10000 Kyoto-shi, Kyoto, Japan, Asia https://www.arkray.co.jp/japanese/index.html
B. Braun View profile 10001+ Chapeltown, Sheffield, United Kingdom, Europe https://www.bbraun.co.uk
Novo Nordisk A/S ADR View profile 66015 Novo Alle 1, Bagsvaerd, Denmark, 2880 https://www.novonordisk.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Insulet Corp View profile 3000 100 Nagog Park, Acton, MA, United States, 01720 https://www.insulet.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Italy diabetes devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes devices market will help companies and investors design strategic landscapes.


Blood glucose monitoring (bgm) devices was the largest segment with a revenue share of 68.03% in 2025. Horizon Databook has segmented the Italy diabetes devices market based on insulin delivery devices, blood glucose monitoring (bgm) devices covering the revenue growth of each sub-segment from 2021 to 2033.


The government of Italy is primary purchaser of medical devices in the country. Public hospitals account for around 75% of sales of medical devices, while the remaining 25% of sales are made to the private sector. The healthcare system of Italy is a region-based national health service that provides universal coverage, almost free of charge, at the point of delivery. 

Italy's diabetes devices market is expanding, and there are numerous opportunities for the U.S. companies. Medical devices, including diabetes devices, are among the best avenue generators in the country.

Reasons to subscribe to Italy diabetes devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Italy diabetes devices market databook

  • Our clientele includes a mix of diabetes devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Italy diabetes devices market , including forecasts for subscribers. This country databook contains high-level insights into Italy diabetes devices market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Italy Self-Monitoring Devices - Diabetes Devices Market size, 2025 - 2033 (US$M)

Italy Diabetes Devices Market Outlook Share, 2025 & 2033 (US$M)

Italy Self-Monitoring Devices - Diabetes Devices Market size, 2025 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online